Summary
We have released the latest research "The Future of Respiratory Diseases Therapeutics-
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by our team of industry experts.
Scope
The scope of this report includes:
- Annualized market data for the respiratory diseases therapeutics market from 2000 to 2008, forecast forward to 2015
- Analysis of the leading therapeutic segments including asthma, chronic obstructive pulmonary disease (COPD), pulmonary hypertension and cystic fibrosis
- Analysis of the respiratory diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
- Market characterization of the respiratory diseases therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns
- Key drivers and barriers that have a significant impact on the market
- Coverage of pipeline molecules in various phases of drug development
- Competitive benchmarking of leading companies. The key companies studied in this report are Novartis AG, AstraZeneca and Merck & Co
- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global respiratory diseases therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to
- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
- Develop key strategic initiatives by understanding key focus areas of leading companies
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps
Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Global Respiratory Therapeutics Market : Scope of Research
2.1 Introduction
2.2 Report Guidance
3 Global Respiratory Therapeutics Market : Market Characteraization
3.1 Market Forecasts
3.2 Branded Vs Generics
3.3 Average Cost of Therapy
3.4 Volume
3.5 Usage Patterns
3.5.1 Diseased Population
3.5.2 Treatment Seeking Population
3.5.3 Diagnosed Population
3.5.4 Prescription Population
3.5.5 Usage Patterns
3.5.6 Global Revenue Distribution Indication Wise
4 Global Asthma Therapeutics Market
4.1 Market Forecasts
4.2 Average Cost of Therapy
4.3 Volume
4.4 Usage Patterns
4.4.1 Diseased Population
4.4.2 Treatment Seeking Population
4.4.3 Diagnosed Population
4.4.4 Prescription Population
4.4.5 Usage Patterns
5 Global COPD Therapeutics Market
5.1 Market Forecasts
5.2 Average Cost of Therapy
5.3 Volume
5.4 Usage Patterns
5.4.1 Diseased Population
5.4.2 Treatment Seeking Population
5.4.3 Diagnosed Population
5.4.4 Prescription Population
5.4.5 Usage Patterns
6 Global Pulmonary Hypertension Therapeutics Market
6.1 Market Forecasts
6.2 Volume
6.3 Average Cost of Therapy
6.4 Usage Patterns
6.4.1 Diseased Population
6.4.2 Treatment Seeking Population
6.4.3 Diagnosed Population
6.4.4 Prescription Population
6.4.5 Usage Patterns
7 Global Cystic Fibrosis Therapeutics Market
7.1 Market Forecasts
7.2 Volume
7.3 Average Cost of Therapy
7.4 Usage Patterns
7.4.1 Diseased Population
7.4.2 Treatment Seeking Population
7.4.3 Diagnosed Population
7.4.4 Prescription Population
7.4.5 Usage Patterns
8 Global Respiratory Therapeutics Market : Market Drivers and Restraints
8.1 Market Drivers
8.1.1 Steady Increase in the Smoking Population
8.1.2 Stable Increase in Incidence Rates for Respiratory Diseases Disorders
8.1.3 Increase in Awareness Levels of Disease Progression and Etiology
8.2 Market Restraints
8.2.1 Patent Expirations and Entry of Generics Pose a Serious Problem for Primary Manufacturers
8.2.2 Reimbursement Restrictions on Drug Classes for Certain Respiratory Diseases Drug Classes Restricts the Market Growth
8.3 Global Respiratory Therapeutics Market: Unmet Needs
8.4 Global Respiratory Therapeutics Market: Key Market Trends
8.5 Increase in Disease Incidence and Prevalence Rates
8.6 Product Pipeline
8.7 Advertising and Commercialization
8.8 Regulatory Trends ¨C Current Reimbursement Scenario
8.8.1 The Budget Impact on Drug Reimbursements
8.8.2 Reliability on Generic Formulations as a Cost Cutting Measure
9 Global Respiratory Therapeutics Market : Competitive Landscape
9.1 Overview
9.2 Market Share Analysis
9.3 Competitive Profiling
9.3.1 GlaxoSmithKline (GSK)
9.3.2 AstraZeneca
9.3.3 Merck
9.3.4 Novartis
10 Global Respiratory Therapeutics Market : Strategic Consolidations
10.1 Mergers and Acquisitions
10.1.1 Overview
10.2 Licensing Agreements
10.2.1 Approval
10.2.2 Filed
10.2.3 Phase III
10.2.4 Phase II
10.2.5 Pre-clinical
10.2.6 Discovery
11 Global Respiratory Therapeutics Market : Appendix
11.1 Market Definitions
11.2 Abbreviations
11.3 Research Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
11.3.4 Forecasts
11.3.5 Expert Panel Validation
11.4 Contact Us
11.5 Disclaimer
1.1 List of Tables
Table 1: Global Respiratory Therapeutics Market, Historical Revenues ($m), 2000-2008
Table 2: Global Respiratory Therapeutics Market, Revenue Forecasts ($m), 2008-2015
Table 3: Global Respiratory Therapeutics Market, Revenue ($bn) Segmentation, 2000-2008
Table 4: Global Respiratory Therapeutics Market, Revenue Segmentation, 2008-2015
Table 5: Global Respiratory Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015
Table 6: Global Respiratory Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008
Table 7: Global Respiratory Therapeutics Market, Historical Figures for Volume, 00-2008
Table 8: Global Respiratory Therapeutics Market, Forecasts for Volume, 2008-2015
Table 9: Global Respiratory Therapeutics Market, Historical Figures for Diseased Population, 2000-2008
Table 10: Global Respiratory Therapeutics Market, Forecasts for Diseased Population, 2008-2015
Table 11: Global Respiratory Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008
Table 12: Global Respiratory Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015
Table 13: Global Respiratory Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008
Table 14: Global Respiratory Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015
Table 15: Global Respiratory Therapeutics Market, Historical Figures for Prescription Population, 2000-2008,
Table 16: Global Respiratory Therapeutics Market, Forecasts for Prescription Population, 2008-2015
Table 17: Global Respiratory Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008
Table 18: Global Respiratory Therapeutics Market, Forecasts for Usage Patterns, 2008-2015, November 2009
...
1.2 List of Figures
